JP2003501038A - 蛋白質キナーゼ - Google Patents
蛋白質キナーゼInfo
- Publication number
- JP2003501038A JP2003501038A JP2001500781A JP2001500781A JP2003501038A JP 2003501038 A JP2003501038 A JP 2003501038A JP 2001500781 A JP2001500781 A JP 2001500781A JP 2001500781 A JP2001500781 A JP 2001500781A JP 2003501038 A JP2003501038 A JP 2003501038A
- Authority
- JP
- Japan
- Prior art keywords
- sequence number
- seq
- sequence
- polypeptide
- kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108060006633 protein kinase Proteins 0.000 title description 97
- 102000001253 Protein Kinase Human genes 0.000 title description 96
- 108091000080 Phosphotransferase Proteins 0.000 claims abstract description 277
- 102000020233 phosphotransferase Human genes 0.000 claims abstract description 267
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 259
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 253
- 229920001184 polypeptide Polymers 0.000 claims abstract description 241
- 238000000034 method Methods 0.000 claims abstract description 175
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 67
- 201000010099 disease Diseases 0.000 claims abstract description 50
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 47
- 238000011282 treatment Methods 0.000 claims abstract description 18
- 210000004027 cell Anatomy 0.000 claims description 190
- 108090000623 proteins and genes Proteins 0.000 claims description 161
- 150000007523 nucleic acids Chemical class 0.000 claims description 146
- 108020004707 nucleic acids Proteins 0.000 claims description 114
- 102000039446 nucleic acids Human genes 0.000 claims description 114
- 241000282414 Homo sapiens Species 0.000 claims description 92
- 102000004169 proteins and genes Human genes 0.000 claims description 84
- 239000000523 sample Substances 0.000 claims description 72
- 239000002773 nucleotide Substances 0.000 claims description 60
- 125000003729 nucleotide group Chemical group 0.000 claims description 60
- 210000004899 c-terminal region Anatomy 0.000 claims description 53
- 230000003197 catalytic effect Effects 0.000 claims description 53
- 206010028980 Neoplasm Diseases 0.000 claims description 43
- 150000001413 amino acids Chemical group 0.000 claims description 41
- 230000000694 effects Effects 0.000 claims description 38
- 230000027455 binding Effects 0.000 claims description 34
- 239000012634 fragment Substances 0.000 claims description 34
- 239000013598 vector Substances 0.000 claims description 32
- 238000009396 hybridization Methods 0.000 claims description 25
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 24
- 201000011510 cancer Diseases 0.000 claims description 24
- 239000002853 nucleic acid probe Substances 0.000 claims description 24
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 23
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 23
- 230000000295 complement effect Effects 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 22
- 238000003556 assay Methods 0.000 claims description 21
- 125000006850 spacer group Chemical group 0.000 claims description 20
- 238000012360 testing method Methods 0.000 claims description 18
- 208000035475 disorder Diseases 0.000 claims description 17
- 230000035897 transcription Effects 0.000 claims description 16
- 238000013518 transcription Methods 0.000 claims description 16
- 241000124008 Mammalia Species 0.000 claims description 14
- 210000004408 hybridoma Anatomy 0.000 claims description 12
- 230000003993 interaction Effects 0.000 claims description 12
- 230000009870 specific binding Effects 0.000 claims description 11
- 230000004770 neurodegeneration Effects 0.000 claims description 9
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 9
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 8
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 8
- 208000037765 diseases and disorders Diseases 0.000 claims description 8
- 238000012163 sequencing technique Methods 0.000 claims description 7
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 claims description 2
- 229940043355 kinase inhibitor Drugs 0.000 claims 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 80
- 108700026244 Open Reading Frames Proteins 0.000 description 64
- 125000003275 alpha amino acid group Chemical group 0.000 description 60
- 239000002299 complementary DNA Substances 0.000 description 57
- 150000001875 compounds Chemical class 0.000 description 57
- 108020004414 DNA Proteins 0.000 description 55
- 238000004458 analytical method Methods 0.000 description 53
- 230000014509 gene expression Effects 0.000 description 44
- 210000001519 tissue Anatomy 0.000 description 36
- 230000036961 partial effect Effects 0.000 description 34
- 230000006870 function Effects 0.000 description 33
- 235000001014 amino acid Nutrition 0.000 description 29
- 241001465754 Metazoa Species 0.000 description 28
- 229940024606 amino acid Drugs 0.000 description 28
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 23
- 239000003814 drug Substances 0.000 description 20
- 230000002159 abnormal effect Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 230000001105 regulatory effect Effects 0.000 description 17
- 238000011160 research Methods 0.000 description 17
- 229940079593 drug Drugs 0.000 description 16
- 239000000284 extract Substances 0.000 description 15
- 238000003752 polymerase chain reaction Methods 0.000 description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 14
- 238000001514 detection method Methods 0.000 description 14
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical group C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 14
- 108020004705 Codon Proteins 0.000 description 13
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 13
- 210000000349 chromosome Anatomy 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 13
- 230000000977 initiatory effect Effects 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 241000607479 Yersinia pestis Species 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 12
- 238000012216 screening Methods 0.000 description 12
- 230000001225 therapeutic effect Effects 0.000 description 11
- -1 tyrosine amino acids Chemical class 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000000306 component Substances 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000009261 transgenic effect Effects 0.000 description 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 230000002759 chromosomal effect Effects 0.000 description 9
- 238000010367 cloning Methods 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 108020004999 messenger RNA Proteins 0.000 description 9
- 210000002381 plasma Anatomy 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 238000010171 animal model Methods 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000001413 cellular effect Effects 0.000 description 8
- 238000001415 gene therapy Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- 230000019491 signal transduction Effects 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000000556 agonist Substances 0.000 description 7
- 239000005557 antagonist Substances 0.000 description 7
- 238000004113 cell culture Methods 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 238000002955 isolation Methods 0.000 description 7
- 230000026731 phosphorylation Effects 0.000 description 7
- 238000006366 phosphorylation reaction Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 150000003246 quinazolines Chemical class 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241001529936 Murinae Species 0.000 description 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 230000036470 plasma concentration Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000011664 signaling Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 6
- 231100000041 toxicology testing Toxicity 0.000 description 6
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 6
- 241000701161 unidentified adenovirus Species 0.000 description 6
- 102000038625 CMGCs Human genes 0.000 description 5
- 108091007913 CMGCs Proteins 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 101100485103 Homo sapiens WNK1 gene Proteins 0.000 description 5
- 102100025184 Mitogen-activated protein kinase kinase kinase 13 Human genes 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 5
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 5
- 102100029064 Serine/threonine-protein kinase WNK1 Human genes 0.000 description 5
- 230000001594 aberrant effect Effects 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 230000002559 cytogenic effect Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 5
- 108090001035 mitogen-activated protein kinase kinase kinase 12 Proteins 0.000 description 5
- 210000001236 prokaryotic cell Anatomy 0.000 description 5
- 230000009822 protein phosphorylation Effects 0.000 description 5
- 150000003248 quinolines Chemical class 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 230000005030 transcription termination Effects 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- 108091007914 CDKs Proteins 0.000 description 4
- 102100022789 Calcium/calmodulin-dependent protein kinase type IV Human genes 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- 101100287682 Homo sapiens CAMK2G gene Proteins 0.000 description 4
- 101100126883 Homo sapiens CAMK4 gene Proteins 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 102000043136 MAP kinase family Human genes 0.000 description 4
- 108091054455 MAP kinase family Proteins 0.000 description 4
- 206010027476 Metastases Diseases 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 102100031721 Twinfilin-2 Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000000692 anti-sense effect Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 238000002820 assay format Methods 0.000 description 4
- 125000002619 bicyclic group Chemical group 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 108020001778 catalytic domains Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000002257 embryonic structure Anatomy 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 238000010195 expression analysis Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 238000000520 microinjection Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 125000002950 monocyclic group Chemical group 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 125000004095 oxindolyl group Chemical group N1(C(CC2=CC=CC=C12)=O)* 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000003362 replicative effect Effects 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 239000013603 viral vector Substances 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 102100034741 Cyclin-dependent kinase 20 Human genes 0.000 description 3
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 3
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 3
- 238000009007 Diagnostic Kit Methods 0.000 description 3
- 102000000564 Elongation Factor 2 Kinase Human genes 0.000 description 3
- 108010016831 Elongation Factor 2 Kinase Proteins 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101000945708 Homo sapiens Cyclin-dependent kinase 20 Proteins 0.000 description 3
- 101001051723 Homo sapiens Ribosomal protein S6 kinase alpha-6 Proteins 0.000 description 3
- 101001026885 Homo sapiens Serine/threonine-protein kinase D3 Proteins 0.000 description 3
- 101000654491 Homo sapiens Serine/threonine-protein kinase SIK3 Proteins 0.000 description 3
- 101000665442 Homo sapiens Serine/threonine-protein kinase TBK1 Proteins 0.000 description 3
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 3
- 101000795921 Homo sapiens Twinfilin-2 Proteins 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 102100023482 Mitogen-activated protein kinase 14 Human genes 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 208000001647 Renal Insufficiency Diseases 0.000 description 3
- 108010034782 Ribosomal Protein S6 Kinases Proteins 0.000 description 3
- 102000009738 Ribosomal Protein S6 Kinases Human genes 0.000 description 3
- 102100024897 Ribosomal protein S6 kinase alpha-6 Human genes 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 102100037311 Serine/threonine-protein kinase D3 Human genes 0.000 description 3
- 102100031445 Serine/threonine-protein kinase SIK3 Human genes 0.000 description 3
- 102100038192 Serine/threonine-protein kinase TBK1 Human genes 0.000 description 3
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000033115 angiogenesis Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 210000002459 blastocyst Anatomy 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 239000000562 conjugate Substances 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 230000037433 frameshift Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 201000006370 kidney failure Diseases 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 230000007781 signaling event Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 239000006226 wash reagent Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- RYCSNJCJOVQGBC-UHFFFAOYSA-N 3-(1-cyclopropyl-2h-pyridin-4-yl)-1h-quinolin-2-one Chemical class O=C1NC2=CC=CC=C2C=C1C(C=C1)=CCN1C1CC1 RYCSNJCJOVQGBC-UHFFFAOYSA-N 0.000 description 2
- FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical group NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108020004491 Antisense DNA Proteins 0.000 description 2
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000701822 Bovine papillomavirus Species 0.000 description 2
- 102000019025 Calcium-Calmodulin-Dependent Protein Kinases Human genes 0.000 description 2
- 108010026870 Calcium-Calmodulin-Dependent Protein Kinases Proteins 0.000 description 2
- 102100021534 Calcium/calmodulin-dependent protein kinase kinase 2 Human genes 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 102100031065 Choline kinase alpha Human genes 0.000 description 2
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 description 2
- 102100040858 Dual specificity protein kinase CLK4 Human genes 0.000 description 2
- 102000001301 EGF receptor Human genes 0.000 description 2
- 108060006698 EGF receptor Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101000777314 Homo sapiens Choline kinase alpha Proteins 0.000 description 2
- 101000749298 Homo sapiens Dual specificity protein kinase CLK4 Proteins 0.000 description 2
- 101000613563 Homo sapiens PAS domain-containing serine/threonine-protein kinase Proteins 0.000 description 2
- 101001089248 Homo sapiens Receptor-interacting serine/threonine-protein kinase 4 Proteins 0.000 description 2
- 101000652133 Homo sapiens STE20-like serine/threonine-protein kinase Proteins 0.000 description 2
- 101000661819 Homo sapiens Serine/threonine-protein kinase 17B Proteins 0.000 description 2
- 101000697608 Homo sapiens Serine/threonine-protein kinase 38-like Proteins 0.000 description 2
- 101000709250 Homo sapiens Serine/threonine-protein kinase SIK2 Proteins 0.000 description 2
- 101000864831 Homo sapiens Serine/threonine-protein kinase Sgk3 Proteins 0.000 description 2
- 101000651178 Homo sapiens Striated muscle preferentially expressed protein kinase Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical group OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 108010068306 MAP Kinase Kinase 6 Proteins 0.000 description 2
- 241001302042 Methanothermobacter thermautotrophicus Species 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 2
- 108091022875 Microtubule Proteins 0.000 description 2
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 2
- 241000713869 Moloney murine leukemia virus Species 0.000 description 2
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 2
- BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 2
- 108091061960 Naked DNA Proteins 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 206010029260 Neuroblastoma Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 102100040902 PAS domain-containing serine/threonine-protein kinase Human genes 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 102100033734 Receptor-interacting serine/threonine-protein kinase 4 Human genes 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 102000001332 SRC Human genes 0.000 description 2
- 101150073911 STK gene Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 102100037959 Serine/threonine-protein kinase 17B Human genes 0.000 description 2
- 102100027898 Serine/threonine-protein kinase 38-like Human genes 0.000 description 2
- 102100034377 Serine/threonine-protein kinase SIK2 Human genes 0.000 description 2
- 102100030071 Serine/threonine-protein kinase Sgk3 Human genes 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 102100027659 Striated muscle preferentially expressed protein kinase Human genes 0.000 description 2
- 101001047016 Tityus serrulatus Potassium channel toxin alpha-KTx 4.1 Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 2
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000008484 agonism Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000002491 angiogenic effect Effects 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000002788 anti-peptide Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 239000003816 antisense DNA Substances 0.000 description 2
- 239000000074 antisense oligonucleotide Substances 0.000 description 2
- 238000012230 antisense oligonucleotides Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000006369 cell cycle progression Effects 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000001163 endosome Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000013020 final formulation Substances 0.000 description 2
- 231100000221 frame shift mutation induction Toxicity 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002414 glycolytic effect Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 244000000013 helminth Species 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000005291 magnetic effect Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000004688 microtubule Anatomy 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 230000030147 nuclear export Effects 0.000 description 2
- 230000012223 nuclear import Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000013081 phylogenetic analysis Methods 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 108020001580 protein domains Proteins 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- 230000006916 protein interaction Effects 0.000 description 2
- 230000004850 protein–protein interaction Effects 0.000 description 2
- 125000004076 pyridyl group Chemical class 0.000 description 2
- 150000003252 quinoxalines Chemical class 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 208000017443 reproductive system disease Diseases 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 238000007423 screening assay Methods 0.000 description 2
- 150000003346 selenoethers Chemical class 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 125000005504 styryl group Chemical group 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 102100028780 AP-1 complex subunit sigma-2 Human genes 0.000 description 1
- 241000203809 Actinomycetales Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 102000002110 C2 domains Human genes 0.000 description 1
- 108050009459 C2 domains Proteins 0.000 description 1
- 101150012716 CDK1 gene Proteins 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 101100316118 Caenorhabditis elegans unc-51 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100033040 Carbonic anhydrase 12 Human genes 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102000008122 Casein Kinase I Human genes 0.000 description 1
- 108010049812 Casein Kinase I Proteins 0.000 description 1
- 108010031425 Casein Kinases Proteins 0.000 description 1
- 102000005403 Casein Kinases Human genes 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000011068 Cdc42 Human genes 0.000 description 1
- 108050001278 Cdc42 Proteins 0.000 description 1
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 235000021538 Chard Nutrition 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
- 102000015792 Cyclin-Dependent Kinase 2 Human genes 0.000 description 1
- 102100039683 Cyclin-G-associated kinase Human genes 0.000 description 1
- 101710113457 Cyclin-G-associated kinase Proteins 0.000 description 1
- 102100038111 Cyclin-dependent kinase 12 Human genes 0.000 description 1
- 102100031684 Cyclin-dependent kinase-like 3 Human genes 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 101150117483 DBF2 gene Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 101150086683 DYRK1A gene Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 241000168726 Dictyostelium discoideum Species 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108700010895 Drosophila ADH Proteins 0.000 description 1
- 108010035533 Drosophila Proteins Proteins 0.000 description 1
- 108700022174 Drosophila Son of Sevenless Proteins 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 101100015729 Drosophila melanogaster drk gene Proteins 0.000 description 1
- 102100028554 Dual specificity tyrosine-phosphorylation-regulated kinase 1A Human genes 0.000 description 1
- 101000944251 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) Calcium/calmodulin-dependent protein kinase cmkA Proteins 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 101100321669 Fagopyrum esculentum FA02 gene Proteins 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000700662 Fowlpox virus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 101150082479 GAL gene Proteins 0.000 description 1
- 102000001267 GSK3 Human genes 0.000 description 1
- 108060006662 GSK3 Proteins 0.000 description 1
- 108010001515 Galectin 4 Proteins 0.000 description 1
- 101000606500 Gallus gallus Inactive tyrosine-protein kinase 7 Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102100033067 Growth factor receptor-bound protein 2 Human genes 0.000 description 1
- 108010067218 Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
- 102000016285 Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
- 102100036738 Guanine nucleotide-binding protein subunit alpha-11 Human genes 0.000 description 1
- 108010078321 Guanylate Cyclase Proteins 0.000 description 1
- 102000014469 Guanylate cyclase Human genes 0.000 description 1
- 108010034145 Helminth Proteins Proteins 0.000 description 1
- 102000009331 Homeodomain Proteins Human genes 0.000 description 1
- 108010048671 Homeodomain Proteins Proteins 0.000 description 1
- 102100032827 Homeodomain-interacting protein kinase 2 Human genes 0.000 description 1
- 101100055680 Homo sapiens AP1S2 gene Proteins 0.000 description 1
- 101000971617 Homo sapiens Calcium/calmodulin-dependent protein kinase kinase 2 Proteins 0.000 description 1
- 101000867855 Homo sapiens Carbonic anhydrase 12 Proteins 0.000 description 1
- 101000884345 Homo sapiens Cyclin-dependent kinase 12 Proteins 0.000 description 1
- 101000777768 Homo sapiens Cyclin-dependent kinase-like 3 Proteins 0.000 description 1
- 101000956145 Homo sapiens Death-associated protein kinase 1 Proteins 0.000 description 1
- 101000838016 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 1A Proteins 0.000 description 1
- 101100283445 Homo sapiens GNA11 gene Proteins 0.000 description 1
- 101000871017 Homo sapiens Growth factor receptor-bound protein 2 Proteins 0.000 description 1
- 101001066401 Homo sapiens Homeodomain-interacting protein kinase 2 Proteins 0.000 description 1
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
- 101001059429 Homo sapiens MAP/microtubule affinity-regulating kinase 3 Proteins 0.000 description 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 1
- 101001018149 Homo sapiens Mitogen-activated protein kinase kinase kinase 21 Proteins 0.000 description 1
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
- 101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 description 1
- 101001051707 Homo sapiens Ribosomal protein S6 kinase delta-1 Proteins 0.000 description 1
- 101000826079 Homo sapiens SRSF protein kinase 3 Proteins 0.000 description 1
- 101000661821 Homo sapiens Serine/threonine-protein kinase 17A Proteins 0.000 description 1
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
- 101001129076 Homo sapiens Serine/threonine-protein kinase N1 Proteins 0.000 description 1
- 101000588545 Homo sapiens Serine/threonine-protein kinase Nek7 Proteins 0.000 description 1
- 101000987317 Homo sapiens Serine/threonine-protein kinase PAK 1 Proteins 0.000 description 1
- 101000987315 Homo sapiens Serine/threonine-protein kinase PAK 3 Proteins 0.000 description 1
- 101000864806 Homo sapiens Serine/threonine-protein kinase Sgk2 Proteins 0.000 description 1
- 101000585344 Homo sapiens Sulfotransferase 1E1 Proteins 0.000 description 1
- 101000891649 Homo sapiens Transcription elongation factor A protein-like 1 Proteins 0.000 description 1
- 101000661459 Homo sapiens Tyrosine-protein kinase STYK1 Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102100028288 Inactive serine/threonine-protein kinase VRK3 Human genes 0.000 description 1
- 101710123193 Inactive serine/threonine-protein kinase VRK3 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102000019223 Interleukin-1 receptor Human genes 0.000 description 1
- 108050006617 Interleukin-1 receptor Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 244000003342 Lilium longiflorum Species 0.000 description 1
- 235000005356 Lilium longiflorum Nutrition 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 102100028920 MAP/microtubule affinity-regulating kinase 3 Human genes 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000010624 Medicago sativa Nutrition 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 108700027648 Mitogen-Activated Protein Kinase 8 Proteins 0.000 description 1
- 102100033054 Mitogen-activated protein kinase kinase kinase 21 Human genes 0.000 description 1
- 241000713862 Moloney murine sarcoma virus Species 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 101100127339 Mus musculus Camkk1 gene Proteins 0.000 description 1
- 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108010074596 Myosin-Light-Chain Kinase Proteins 0.000 description 1
- 206010068871 Myotonic dystrophy Diseases 0.000 description 1
- 101800000135 N-terminal protein Proteins 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010029888 NIMA-Related Kinases Proteins 0.000 description 1
- 102000001783 NIMA-Related Kinases Human genes 0.000 description 1
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101800001452 P1 proteinase Proteins 0.000 description 1
- 101150048267 PAK3 gene Proteins 0.000 description 1
- 102000042846 PKC family Human genes 0.000 description 1
- 108091082203 PKC family Proteins 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 102000005877 Peptide Initiation Factors Human genes 0.000 description 1
- 108010044843 Peptide Initiation Factors Proteins 0.000 description 1
- 240000008839 Petunia integrifolia Species 0.000 description 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101150040459 RAS gene Proteins 0.000 description 1
- 101150076031 RAS1 gene Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100022122 Ras-related C3 botulinum toxin substrate 1 Human genes 0.000 description 1
- 108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 102100024913 Ribosomal protein S6 kinase delta-1 Human genes 0.000 description 1
- 241000231739 Rutilus rutilus Species 0.000 description 1
- 102000000395 SH3 domains Human genes 0.000 description 1
- 108050008861 SH3 domains Proteins 0.000 description 1
- 102100023017 SRSF protein kinase 3 Human genes 0.000 description 1
- 102100030571 STE20-like serine/threonine-protein kinase Human genes 0.000 description 1
- 101000744436 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Trans-acting factor D Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 102100026758 Serine/threonine-protein kinase 16 Human genes 0.000 description 1
- 102100037955 Serine/threonine-protein kinase 17A Human genes 0.000 description 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
- 102100026219 Serine/threonine-protein kinase N3 Human genes 0.000 description 1
- 102100031400 Serine/threonine-protein kinase Nek7 Human genes 0.000 description 1
- 102100027911 Serine/threonine-protein kinase PAK 3 Human genes 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000251778 Squalus acanthias Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101150108263 Stk16 gene Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108090000925 TNF receptor-associated factor 2 Proteins 0.000 description 1
- 102100034779 TRAF family member-associated NF-kappa-B activator Human genes 0.000 description 1
- 241000248418 Tetrahymena pyriformis Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 101710112470 Twinfilin-2 Proteins 0.000 description 1
- 102100037781 Tyrosine-protein kinase STYK1 Human genes 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 101000962654 Vespa orientalis Mastoparan Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 101000752225 Xenopus laevis Low density lipoprotein receptor adapter protein 1-A Proteins 0.000 description 1
- HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000007801 affinity label Substances 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000006229 amino acid addition Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000005775 apoptotic pathway Effects 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000035578 autophosphorylation Effects 0.000 description 1
- 239000013602 bacteriophage vector Substances 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000012820 cell cycle checkpoint Effects 0.000 description 1
- 230000023359 cell cycle switching, meiotic to mitotic cell cycle Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000003200 chromosome mapping Methods 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000012761 co-transfection Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000000448 cultured tumor cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000009109 downstream regulation Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 244000088681 endo Species 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000004220 glutamic acid Chemical group 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 210000002288 golgi apparatus Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 101150098203 grb2 gene Proteins 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 102000034345 heterotrimeric G proteins Human genes 0.000 description 1
- 108091006093 heterotrimeric G proteins Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 102000044476 human PAK1 Human genes 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 239000012133 immunoprecipitate Substances 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 108010058266 p21-Activated Kinases Proteins 0.000 description 1
- 102000006271 p21-Activated Kinases Human genes 0.000 description 1
- 108700025694 p53 Genes Proteins 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000863 peptide conjugate Substances 0.000 description 1
- 230000011340 peptidyl-tyrosine autophosphorylation Effects 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 1
- 238000003322 phosphorimaging Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 description 1
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
- 230000008884 pinocytosis Effects 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 108010061269 protein kinase D Proteins 0.000 description 1
- 108010061151 protein kinase N Proteins 0.000 description 1
- 239000003909 protein kinase inhibitor Substances 0.000 description 1
- 230000004844 protein turnover Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 108010062302 rac1 GTP Binding Protein Proteins 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000031267 regulation of DNA replication Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 101150008563 spir gene Proteins 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 102000009076 src-Family Kinases Human genes 0.000 description 1
- 108010087686 src-Family Kinases Proteins 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000001608 teratocarcinoma Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000012256 transgenic experiment Methods 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 108010002164 tyrosine receptor Proteins 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 230000009107 upstream regulation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13650399P | 1999-05-28 | 1999-05-28 | |
| US60/136,503 | 1999-05-28 | ||
| PCT/US2000/014842 WO2000073469A2 (en) | 1999-05-28 | 2000-05-26 | Protein kinases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003501038A true JP2003501038A (ja) | 2003-01-14 |
| JP2003501038A5 JP2003501038A5 (enExample) | 2007-06-14 |
Family
ID=22473127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001500781A Withdrawn JP2003501038A (ja) | 1999-05-28 | 2000-05-26 | 蛋白質キナーゼ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060234344A1 (enExample) |
| EP (1) | EP1180151A2 (enExample) |
| JP (1) | JP2003501038A (enExample) |
| AU (1) | AU5173400A (enExample) |
| CA (1) | CA2383244A1 (enExample) |
| WO (1) | WO2000073469A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008522596A (ja) * | 2004-12-10 | 2008-07-03 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 血清／糖質コルチコイド調節キナーゼの使用 |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020028772A1 (en) * | 1997-05-21 | 2002-03-07 | Children's Med. Corporation, | Modulators of activity of G-protein-coupled receptor kinases |
| US7037891B2 (en) | 1997-05-21 | 2006-05-02 | Children's Medical Center Corporation | Methods of modulating G-protein-coupled receptor kinase-associated signal transduction |
| AU5254399A (en) | 1998-08-04 | 2000-02-28 | Immunex Corporation | Human cdnas encoding polypeptides having kinase functions |
| AU5252799A (en) | 1998-08-04 | 2000-02-28 | Immunex Corporation | Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| US20030028004A1 (en) * | 2000-12-22 | 2003-02-06 | Millennium Pharmaceuticals, Inc. | 68730 and 69112, protein kinase molecules and uses therefor |
| US20020077312A1 (en) * | 2000-09-25 | 2002-06-20 | Millennium Pharmaceuticals, Inc. | 3700, a novel human protein kinase and uses therefor |
| US6660490B2 (en) * | 1998-12-11 | 2003-12-09 | Millennnium Pharmaceuticals, Inc. | CARK protein and nucleic acid molecules and uses therefor |
| US6261818B1 (en) * | 1998-12-11 | 2001-07-17 | Millennium Pharmaceuticals, Inc. | CARK protein and nucleic acid molecules and uses therefor |
| EP1181374A4 (en) | 1999-05-28 | 2003-04-23 | Immunex Corp | NEW HUMAN AND MURINE KINASES |
| US7001752B1 (en) | 1999-05-28 | 2006-02-21 | Immunex Corporation | Murine and human kinases |
| US6656698B1 (en) * | 1999-06-30 | 2003-12-02 | Millennium Pharmaceuticals, Inc. | 12832, a novel human kinase-like molecule and uses thereof |
| EP1484408A1 (en) * | 1999-09-28 | 2004-12-08 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| JP2003510082A (ja) * | 1999-09-28 | 2003-03-18 | レキシコン・ジェネティクス・インコーポレーテッド | ヒトキナーゼタンパク質およびそれをコードするポリヌクレオチド |
| US6716616B1 (en) | 1999-09-28 | 2004-04-06 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| JP2003511028A (ja) * | 1999-10-07 | 2003-03-25 | ジェネンテック・インコーポレーテッド | 新規ポリペプチド、その核酸および新脈管形成および血管新生におけるその使用のための方法 |
| US6428980B1 (en) | 1999-11-16 | 2002-08-06 | Rigel Pharmaceuticals, Inc. | Nucleic acids encoding RIP3 associated cell cycle proteins |
| WO2001038503A2 (en) * | 1999-11-24 | 2001-05-31 | Sugen, Inc. | Novel human protein kinases and protein kinase-like enzymes |
| JP2005503751A (ja) * | 1999-12-10 | 2005-02-10 | インサイト・ゲノミックス・インコーポレイテッド | 細胞外マトリックスおよび細胞接着分子 |
| GB9929542D0 (en) * | 1999-12-14 | 2000-02-09 | Glaxo Wellcome Kk | Ikk4 |
| WO2001059081A2 (en) * | 2000-02-09 | 2001-08-16 | Millennium Pharmaceuticals, Inc. | Methods for using 20893, a human protein kinase |
| EP1255819A2 (en) * | 2000-02-17 | 2002-11-13 | Incyte Genomics, Inc. | Human kinases |
| US6864078B2 (en) | 2000-02-29 | 2005-03-08 | Millennium Pharmaceuticals, Inc. | 14790, novel protein kinase molecule and uses therefor |
| US7198930B2 (en) | 2000-02-29 | 2007-04-03 | Millennium Pharmaceuticals, Inc. | Human protein kinase, phosphatase, and protease family members and uses thereof |
| US20020192204A1 (en) * | 2000-08-21 | 2002-12-19 | Rosana Kapeller-Libermann | 15985, a novel human serine/threonine protein kinase family member and uses thereof |
| WO2001066762A1 (en) * | 2000-03-08 | 2001-09-13 | Merck Patent Gmbh | Human extracellular signal regulated kinases |
| US6458561B1 (en) | 2000-03-13 | 2002-10-01 | Incyte Genomics, Inc. | Human NIM1 kinase |
| EP1272640A2 (en) | 2000-03-24 | 2003-01-08 | Millennium Pharmaceuticals, Inc. | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| US20030198953A1 (en) * | 2000-03-30 | 2003-10-23 | Spytek Kimberly A. | Novel proteins and nucleic acids encoding same |
| US20020090701A1 (en) * | 2000-04-13 | 2002-07-11 | Rosana Kapeller-Libermann | 14257 novel protein kinase molecules and their uses therefor |
| EP1276873A2 (en) | 2000-04-25 | 2003-01-22 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| WO2001081558A2 (en) * | 2000-04-25 | 2001-11-01 | Millennium Pharmaceuticals, Inc. | 13295 novel protein kinase molecules and uses therefor |
| JP2003532412A (ja) * | 2000-05-12 | 2003-11-05 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 新規セリン−トレオニン・キナーゼ−４ |
| CA2408468A1 (en) * | 2000-05-12 | 2001-11-15 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Serine-threonine kinase-3 |
| WO2001090160A2 (en) * | 2000-05-26 | 2001-11-29 | Bayer Aktiengesellschaft | REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
| US6416990B2 (en) | 2000-06-06 | 2002-07-09 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6413756B2 (en) * | 2000-06-06 | 2002-07-02 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6323016B1 (en) | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| AU2001268525A1 (en) * | 2000-06-15 | 2001-12-24 | Incyte Genomics, Inc. | Human kinases |
| JP2004502429A (ja) * | 2000-07-05 | 2004-01-29 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 新規ヒト・セリン−トレオニン・キナーゼ |
| AU2001279106A1 (en) * | 2000-07-28 | 2002-02-13 | Chiron Corporation | Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| EP1307546A2 (en) * | 2000-08-03 | 2003-05-07 | 1149336 Ontario Inc. | Ampk-related serine/threonine kinase, designated snark |
| US6759221B1 (en) | 2000-08-18 | 2004-07-06 | Millennium Pharmaceuticals, Inc. | 14189, a novel human kinase and uses thereof |
| US6455291B1 (en) * | 2000-08-24 | 2002-09-24 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6555352B2 (en) * | 2000-08-31 | 2003-04-29 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6372468B1 (en) * | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| JP2004514425A (ja) * | 2000-09-20 | 2004-05-20 | カインテック ファーマシューティカルズ インコーポレーティッド | 癌関連プロテインキナーゼおよびその使用方法 |
| WO2002031129A2 (en) | 2000-10-12 | 2002-04-18 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
| AU2002220630A1 (en) * | 2000-10-16 | 2002-04-29 | Bayer Aktiengesellschaft | Regulation of human serine-threonine protein kinase |
| US7150976B2 (en) | 2000-10-16 | 2006-12-19 | Bayer Healthcare Ag | Regulation of human serine-threonine protein kinase |
| EP1443117B1 (en) * | 2000-11-09 | 2010-08-11 | University Of Virginia Patent Foundation | Human testis specific serine/threonine kinase |
| EP1339866B1 (en) * | 2000-11-09 | 2010-09-01 | University Of Virginia Patent Foundation | Human testis specific serine/threonine kinase |
| CA2430624A1 (en) * | 2000-12-08 | 2002-06-13 | Ming-Hui Wei | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| JP2004530417A (ja) | 2000-12-12 | 2004-10-07 | レキシコン・ジェネティクス・インコーポレーテッド | 新規ヒトキナーゼおよびそれをコードするポリヌクレオチド |
| EP1676917A3 (en) * | 2000-12-12 | 2006-07-12 | Lexicon Genetics Incorporated | Novel human kinases and uses thereof |
| US6410294B1 (en) * | 2000-12-13 | 2002-06-25 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002048328A2 (en) * | 2000-12-14 | 2002-06-20 | Pe Corporation (Ny) | Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| US7119185B2 (en) * | 2000-12-21 | 2006-10-10 | Trustees Of The University Of Pennsylvania | Hormonally up-regulated, neu-tumor-associated kinase |
| US7049118B2 (en) | 2001-01-03 | 2006-05-23 | Bayer Healthcare Ag | Regulation of human serine-threonine protein kinase |
| WO2002055681A2 (en) * | 2001-01-11 | 2002-07-18 | Bayer Ag | Regulation of human tau-tubulin kinase |
| DE10102797A1 (de) * | 2001-01-22 | 2003-05-08 | Deutsches Krebsforsch | HIPK-Kinasen und deren Verwendung zur Beeinflussung der Zellteilung und Zellproliferation |
| US6686176B2 (en) * | 2001-01-23 | 2004-02-03 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| EP1227156A3 (en) * | 2001-01-30 | 2004-01-02 | Aeomica, Inc. | A human protein kinase domain-containing protein |
| US6492154B2 (en) * | 2001-01-31 | 2002-12-10 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002070678A2 (en) * | 2001-02-05 | 2002-09-12 | Bayer Aktiengesellschaft | Regulation of human serine/threonine protein kinase |
| US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
| US20030036183A1 (en) * | 2001-05-10 | 2003-02-20 | Boylan John F. | Serine threonine kinase member, h2520-40 |
| DE60237917D1 (de) | 2001-06-05 | 2010-11-18 | Exelixis Inc | Gfats als modifikatoren des p53-wegs und verwendungsverfahren |
| WO2002099096A1 (en) * | 2001-06-07 | 2002-12-12 | Bayer Aktiengesellschaft | Regulation of human serine/threonine protein kinase-like enzyme |
| AU2002312976A1 (en) * | 2001-06-07 | 2002-12-16 | Bayer Aktiengesellschaft | Human serine/threonine protein kinase-like enzyme |
| JP4491567B2 (ja) * | 2001-07-19 | 2010-06-30 | 財団法人新産業創造研究機構 | ヒト由来のスフィンゴシン・キナーゼ１に結合する新規タンパク質、及び当該タンパク質をコードするポリヌクレオチド |
| JP2005508169A (ja) * | 2001-10-31 | 2005-03-31 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | ２０７５０を使用した細胞増殖障害の診断および処置のための方法および組成物 |
| US20050053938A1 (en) * | 2001-11-27 | 2005-03-10 | Kohler Rainer H. | Regulation of human serine/threonine protein kinase |
| AU2002359869A1 (en) * | 2001-12-28 | 2003-07-24 | The Trustees Of Columbia University In The City Of New York | Pak5-related compositions and methods |
| CA2478118A1 (en) * | 2002-03-05 | 2003-09-18 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US7189551B2 (en) | 2002-03-20 | 2007-03-13 | Bioptik Technology, Inc. | Human RPS6KA6-related gene variant associated with lung cancers |
| CN1674929B (zh) | 2002-08-14 | 2013-07-17 | 赛伦斯治疗公司 | 蛋白激酶Nβ的应用 |
| EP1393742A1 (en) * | 2002-08-14 | 2004-03-03 | atugen AG | Use of protein kinase N beta |
| JPWO2004018669A1 (ja) * | 2002-08-21 | 2005-12-08 | 株式会社プロテイン・エクスプレス | 塩誘導性キナーゼ２及びその用途 |
| WO2004032877A2 (en) | 2002-10-10 | 2004-04-22 | Wyeth | Compositions, organisms and methodologies employing a novel human kinase |
| US20040096890A1 (en) * | 2002-10-10 | 2004-05-20 | Wyeth | Compositions, organisms and methodologies employing a novel human kinase |
| EP1554385A2 (en) | 2002-10-24 | 2005-07-20 | Wyeth | Calcineurin-like human phoshphoesterase |
| WO2004050831A2 (en) | 2002-11-27 | 2004-06-17 | Wyeth | Compositions, organisms and methodologies employing a novel human kinase |
| WO2004098539A2 (en) | 2003-04-30 | 2004-11-18 | Incyte Corporation | Kinases and phosphatases |
| GB0328928D0 (en) * | 2003-12-12 | 2004-01-14 | Cancer Rec Tech Ltd | Materials and methods relating to cell cycle control |
| EP1830888B1 (en) | 2004-12-27 | 2015-08-05 | Silence Therapeutics GmbH | Lipid complexes coated with peg and their use |
| CA2658550C (en) | 2006-07-21 | 2018-06-19 | Silence Therapeutics Ag | Means for inhibiting the expression of protein kinase 3 |
| US8399637B2 (en) * | 2006-08-24 | 2013-03-19 | The Trustees Of The University Of Pennsylvania | Nucleic acids encoding proteins for modulating Na,K-ATPase |
| EP2486130A1 (en) * | 2009-10-06 | 2012-08-15 | Tallinn University Of Technology | Inhibition or activation of serine/threonine ulk3 kinase activity |
| WO2025006571A1 (en) * | 2023-06-26 | 2025-01-02 | University Of Kentucky Research Foundation | Targeted destruction of pask by peptide-based degron |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69331994T2 (de) * | 1992-08-31 | 2003-02-20 | Massachusetts Institute Of Technology, Cambridge | Dna kodierend für die häm-regulierte kinase des eukaryontischen initiationsfaktors 2-alpha |
| CA2249742A1 (en) * | 1996-03-15 | 1997-09-18 | Steven G. Reed | Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| IL127363A (en) * | 1996-06-10 | 2007-05-15 | Immunex Corp | Nucleic acid encoding kinase activated by (ITAK) ACTIVATED KINASE –a - TNF / 1 –IL, such polypeptides Methods for their preparation |
| US5863729A (en) * | 1996-07-09 | 1999-01-26 | Washington University | DNA sequences encoding human TcAK1 kinase |
| US5863780A (en) * | 1996-09-12 | 1999-01-26 | Incyte Pharmaceuticals, Inc. | Human Protein Kinases |
| JP2002512507A (ja) * | 1997-01-21 | 2002-04-23 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌蛋白およびそれらをコードするポリヌクレオチド |
| CA2280206A1 (en) * | 1997-02-07 | 1998-08-13 | Merck & Co., Inc. | Cyclin-dependent protein kinase |
| US6479274B1 (en) * | 1997-02-13 | 2002-11-12 | Amrad Operations Pty., Ltd. | DNA molecules encoding human HELA2 or testisin serine proteinases |
| DE19708173A1 (de) * | 1997-02-28 | 1998-09-03 | Dade Behring Marburg Gmbh | Zellvolumenregulierte humane Kinase h-sgk |
| US5965420A (en) * | 1997-03-05 | 1999-10-12 | Smithkline Beecham Corporation | Human protein kinases hYAK3 |
| US5885803A (en) * | 1997-06-19 | 1999-03-23 | Incyte Pharmaceuticals, Inc. | Disease associated protein kinases |
| JP2001516009A (ja) * | 1997-07-17 | 2001-09-25 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ガン関連核酸及びポリペプチド |
| AU1991899A (en) * | 1997-12-19 | 1999-07-12 | Karolinska Innovations Ab | Molecules associated with the human fused gene |
| AU1691499A (en) * | 1997-12-26 | 1999-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel kinase |
| US6432668B1 (en) * | 1997-12-30 | 2002-08-13 | Chiron Corporation | Polynucleotides encoding human cyclin-dependent kinase (hPFTAIRE) |
| US5962232A (en) * | 1998-01-30 | 1999-10-05 | Incyte Pharmaceuticals, Inc. | Protein kinase molecules |
| EP1073756A4 (en) * | 1998-03-26 | 2003-01-22 | Gene Logic Inc | IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN CARDIAC TISSUE |
| WO1999050395A1 (fr) * | 1998-03-27 | 1999-10-07 | Helix Research Institute | Serine-threonine proteine-kinase exprimee dans le rein |
| CA2327259A1 (en) * | 1998-05-05 | 1999-11-11 | Incyte Pharmaceuticals, Inc. | Human transcriptional regulator molecules |
| WO1999058558A2 (en) * | 1998-05-13 | 1999-11-18 | Incyte Pharmaceuticals, Inc. | Cell signaling proteins |
| WO1999064589A1 (en) * | 1998-06-11 | 1999-12-16 | Astrazeneca Ab | Human receptor tyrosine kinase |
| WO2000006728A2 (en) * | 1998-07-28 | 2000-02-10 | Incyte Pharmaceuticals, Inc. | Phosphorylation effectors |
| US6262228B1 (en) * | 1998-08-17 | 2001-07-17 | Tularik Inc. | IRAK3 polypeptides and methods |
| US6183962B1 (en) * | 1998-09-09 | 2001-02-06 | Millennium Pharmaceuticals, Inc. | Protein kinase molecules and uses therefor |
| US6013455A (en) * | 1998-10-15 | 2000-01-11 | Incyte Pharmaceuticals, Inc. | Protein kinase homologs |
| DE69937159T2 (de) * | 1998-12-14 | 2008-06-26 | University Of Dundee, Dundee | Verfahren zur Aktivierung von SGK durch Phosphorylierung. |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| EP1192257A2 (en) * | 1999-03-18 | 2002-04-03 | Incyte Pharmaceuticals, Inc. | Human regulators of intracellular phosphorylation |
| CA2383592A1 (en) * | 1999-03-31 | 2000-10-05 | Curagen Corporation | 2384891 acids including open reading frames encoding polypeptides; orfx |
-
2000
- 2000-05-26 JP JP2001500781A patent/JP2003501038A/ja not_active Withdrawn
- 2000-05-26 EP EP00936414A patent/EP1180151A2/en not_active Withdrawn
- 2000-05-26 CA CA002383244A patent/CA2383244A1/en not_active Abandoned
- 2000-05-26 WO PCT/US2000/014842 patent/WO2000073469A2/en not_active Ceased
- 2000-05-26 AU AU51734/00A patent/AU5173400A/en not_active Abandoned
-
2006
- 2006-03-17 US US11/377,316 patent/US20060234344A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008522596A (ja) * | 2004-12-10 | 2008-07-03 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 血清／糖質コルチコイド調節キナーゼの使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5173400A (en) | 2000-12-18 |
| US20060234344A1 (en) | 2006-10-19 |
| WO2000073469A2 (en) | 2000-12-07 |
| CA2383244A1 (en) | 2000-12-07 |
| EP1180151A2 (en) | 2002-02-20 |
| WO2000073469A3 (en) | 2001-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003501038A (ja) | 蛋白質キナーゼ | |
| EP1073723B1 (en) | Ste20-related protein kinases | |
| EP1051500B1 (en) | Diagnosis and treatment of aur1 and/or aur2 related disorders | |
| JP3944241B2 (ja) | Ａｕｒ―１および／またはａｕｒ―２関連疾患の診断および処置 | |
| US20040197792A1 (en) | Novel Kinases | |
| JP2001523081A (ja) | プロビン チロシン キナーゼ（ＰＹＫ２）、そのｃＤＮＡクローニングおよびその用途 | |
| CA2394803A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| JP2003507016A (ja) | 新規な蛋白質ホスファターゼおよびホスファターゼ関連疾患の診断および治療 | |
| US20060140954A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| JP2003517836A (ja) | 哺乳動物蛋白質ホスファターゼ | |
| US6670167B1 (en) | Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof | |
| AU9223198A (en) | Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods | |
| CA2331889A1 (en) | Nek-related and bub1-related protein kinases | |
| US6495353B1 (en) | Human orthologues of wart | |
| JP2002525035A (ja) | 新規なリボゾームｓ６プロテインキナーゼの同定および機能的なキャラクタライゼーション | |
| US20030211989A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| US20020090703A1 (en) | Mammalian protein phosphatases | |
| US7029912B1 (en) | Tyrosine kinase substrate(Tks) proteins | |
| US20050084877A1 (en) | Mammalian protein phosphatases | |
| US20040048310A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| US20060019294A1 (en) | Tyrosine kinase substrate (Tks) proteins | |
| JP2003510010A (ja) | Ｐｙｋ２結合蛋白質 | |
| EP1533378A2 (en) | Tyrosine kinase substrate protein Tks7 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070412 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070412 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20080526 |